DMII (Drugs Made In America Acquisition II) Pre-Tax Income: $8.59 Mil (TTM As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Pre-Tax Income?

Drugs Made In America Acquisition II DMII 15 Pre-Tax Income is $8.59 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Pretax income is the income that a company earns before paying income taxes. Drugs Made In America Acquisition II's pretax income for the three months ended in Mar. 2026 was $4.34 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2026 was $8.59 Mil. Drugs Made In America Acquisition II's pretax margin was %.

Drugs Made In America Acquisition II  (NAS:DMII) Pre-Tax Income Explanation

Drugs Made In America Acquisition II's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pretax Income/Revenue
=4.338/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Pre-Tax Income Related Terms

Drugs Made In America Acquisition II Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Pre-Tax Income Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Pre-Tax Income
0.00 4.19

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pre-Tax Income Get a 7-Day Free Trial -0.06 -0.04 -0.05 4.33 4.34

DMII vs BCSS, EVAC, CEPF: Pre-Tax Income Comparison

For the Shell Companies subindustry, Drugs Made In America Acquisition II's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drugs Made In America Acquisition II Pre-Tax Income vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Drugs Made In America Acquisition II's Pre-Tax Income falls into.


DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Pre-Tax Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Drugs Made In America Acquisition II's Pretax Income for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.3+0.554+0+4.934+-0.0010000000000003
=4.19

Drugs Made In America Acquisition II's Pretax Income for the quarter that ended in Mar. 2026 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.102+0+0+4.44+0
=4.34

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $8.59 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Pre-Tax Income of $8.59 Mil as of Mar. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Pre-Tax Income too high?
Drugs Made In America Acquisition II's current Pre-Tax Income is $8.59 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Pre-Tax Income compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Pre-Tax Income of $8.59 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Diversified Financial Services company?
A good Pre-Tax Income depends on the Diversified Financial Services industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Pre-Tax Income is $8.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Pre-Tax Income of $8.59 Mil. The current Pre-Tax Income is $8.59 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Pre-Tax Income is $8.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price